[1]
Ntoukaki , E. et al. 2023. A Promising Antigen-specific Immunotherapy for the Treatment of Myasthenia Gravis. RRNMF Neuromuscular Journal. 4, 3 (Aug. 2023). DOI:https://doi.org/10.17161/rrnmf.v4i3.19494.